Accelerating Inflammation Resolution to CounterACT Chemical Injury

加速炎症消退以对抗化学损伤

基本信息

  • 批准号:
    8416589
  • 负责人:
  • 金额:
    $ 40.43万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2012
  • 资助国家:
    美国
  • 起止时间:
    2012-09-19 至 2014-08-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Exposures to chemical threat agents oftentimes induce strong inflammatory tissue responses that contribute to morbidity and prevent tissue repair and recovery. Pulmonary exposures to chlorine trigger a potent inflammatory response resulting in vascular leakage, cardiopulmonary depression, neutrophil infiltration and a pulmonary and systemic hypercytokinemia comparable to the cytokine storm observed in sepsis. Similar inflammatory responses are observed after inhalation exposures to phosgene and acidic (HCl) or alkaline gases (ammonia) and reactive industrial chemicals such as acrolein, and to riot control agents (CS, CN or CR), and following cutaneous exposures to vesicants. Classical anti-inflammatory treatments against chemical injury have focused on interference with target pathways involved in the initiation and maintenance of inflammation. These strategies have only been partially successful, due to the large variety of pathways and pathologies involved. The inflammatory response is divided into three temporal phases, initiation, amplification and maintenance, and resolution. A new area of inflammation research has focused on the process of inflammation resolution, an active mechanism involving the activation of signaling pathways during inflammation initiation, and the later generation of omega 3 fatty-acid derived inflammation-resolving mediators that activate resolution mechanisms. In our preliminary studies we observe that post exposure treatment with Resolvin D1, an inflammation-resolving agent, strongly inhibited skin edema formation and inflammation in mice exposed to the vesicant, CEES, and the electrophilic riot control agent, CS. Our proposed studies are designed to 1: Examine the effects of inflammation-resolving agents in mouse models of cutaneous exposures to vesicants and electrophilic chemical threats and, 2: Study the effects of inflammation-resolving agents on pulmonary injury progression in mice exposed to chlorine and HCl. PUBLIC HEALTH RELEVANCE: Chemical warfare agents and industrial chemicals oftentimes cause severe inflammation that aggravates the injuries and prevents healing. Our proposed research will investigate the therapeutic effects of a group of newly discovered natural drugs that terminate inflammation before it causes tissue damage.
描述(由申请人提供):暴露于化学威胁剂往往会引发强烈的炎症组织反应,导致发病率增加,并阻止组织修复和恢复。肺暴露于氯会引发强烈的炎症反应,导致血管渗漏、心肺抑制、中性粒细胞渗入以及肺和全身高细胞分裂素血症,与败血症时观察到的细胞因子风暴类似。在吸入光气和酸性气体(HCl)或碱性气体(氨)和反应性工业化学品如丙烯醛、防暴剂(CS、CN或CR)以及皮肤暴露于发泡剂后,也观察到类似的炎症反应。针对化学损伤的经典抗炎治疗主要集中在干扰参与炎症启动和维持的靶通路。由于涉及的途径和病理种类繁多,这些策略只取得了部分成功。炎症反应分为启动、放大和维持、消退三个时间阶段。炎症研究的一个新领域集中在炎症消解过程,这是一种活跃的机制,涉及在炎症启动过程中激活信号通路,以及晚一代欧米茄3脂肪酸衍生的炎症消解介质,激活消解机制。在我们的初步研究中,我们观察到,暴露后使用消炎剂Resolvin D1处理,强烈抑制了暴露于发泡剂CEES和亲电暴乱控制剂CS的小鼠皮肤浮肿和炎症的形成。我们拟议的研究旨在1:在皮肤暴露于发泡剂和亲电化学威胁的小鼠模型中检测消炎剂的作用,2:研究消炎剂对氯气和盐酸暴露小鼠肺损伤进展的影响。 与公共卫生相关:化学战剂和工业化学品往往会引起严重的炎症,从而加重伤害并阻止愈合。我们提议的研究将调查一组新发现的天然药物的治疗效果,这些药物在炎症造成组织损伤之前终止炎症。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

SVEN-ERIC JORDT其他文献

SVEN-ERIC JORDT的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('SVEN-ERIC JORDT', 18)}}的其他基金

Nicotine Pouches: Chemical Composition, Toxicity and Behavioral Effects of a New Tobacco Product Category
尼古丁袋:新型烟草产品类别的化学成分、毒性和行为影响
  • 批准号:
    10673370
  • 财政年份:
    2022
  • 资助金额:
    $ 40.43万
  • 项目类别:
Molecular Core
分子核心
  • 批准号:
    9703532
  • 财政年份:
    2020
  • 资助金额:
    $ 40.43万
  • 项目类别:
Anesthetic and synthetic cooling flavors in E-cigarettes: Chemistry and respiratory effects modulating nicotine intake
电子烟中的麻醉剂和合成清凉香料:调节尼古丁摄入量的化学和呼吸效应
  • 批准号:
    9982329
  • 财政年份:
    2018
  • 资助金额:
    $ 40.43万
  • 项目类别:
Mechanisms of Itch in Poison Ivy-Induced Allergic Contact Dermatitis
毒藤引起的过敏性接触性皮炎的瘙痒机制
  • 批准号:
    9164682
  • 财政年份:
    2016
  • 资助金额:
    $ 40.43万
  • 项目类别:
Accelerating Inflammation Resolution to CounterACT Chemical Injury
加速炎症消退以对抗化学损伤
  • 批准号:
    8900466
  • 财政年份:
    2012
  • 资助金额:
    $ 40.43万
  • 项目类别:
Accelerating Inflammation Resolution to CounterACT Chemical Injury
加速炎症消退以对抗化学损伤
  • 批准号:
    8547809
  • 财政年份:
    2012
  • 资助金额:
    $ 40.43万
  • 项目类别:
Counterirritation by Menthol: Molecular Targets and Role in Airway Disease
薄荷醇的抗刺激作用:分子靶标及其在气道疾病中的作用
  • 批准号:
    8022797
  • 财政年份:
    2011
  • 资助金额:
    $ 40.43万
  • 项目类别:
Counter-Irritation by Menthol: Molecular Targets and Role in Airway Disease
薄荷醇抗刺激:分子靶标及其在气道疾病中的作用
  • 批准号:
    8209236
  • 财政年份:
    2011
  • 资助金额:
    $ 40.43万
  • 项目类别:
Counter-Irritation by Menthol: Molecular Targets and Role in Airway Disease
薄荷醇抗刺激:分子靶标及其在气道疾病中的作用
  • 批准号:
    8605272
  • 财政年份:
    2011
  • 资助金额:
    $ 40.43万
  • 项目类别:
Counter-irritation by Menthol: Molecular Targets and Role in Airway Disease
薄荷醇的抗刺激作用:分子靶标及其在气道疾病中的作用
  • 批准号:
    8431661
  • 财政年份:
    2011
  • 资助金额:
    $ 40.43万
  • 项目类别:

相似国自然基金

SIRT5/ammonia信号通路介导适应性自噬在急性心肌梗死中的作用及其机制研究
  • 批准号:
    81900312
  • 批准年份:
    2019
  • 资助金额:
    20.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Powering Small Craft with a Novel Ammonia Engine
用新型氨发动机为小型船只提供动力
  • 批准号:
    10099896
  • 财政年份:
    2024
  • 资助金额:
    $ 40.43万
  • 项目类别:
    Collaborative R&D
STTR Phase I: Microwave-Enhanced Modular Ammonia Synthesis
STTR 第一阶段:微波增强模块化氨合成
  • 批准号:
    2335104
  • 财政年份:
    2024
  • 资助金额:
    $ 40.43万
  • 项目类别:
    Standard Grant
ENTICE: Enhanced Ammonia Cracking to Improve Engine Combustion and Emissions
ENTICE:增强氨裂解以改善发动机燃烧和排放
  • 批准号:
    10096979
  • 财政年份:
    2024
  • 资助金额:
    $ 40.43万
  • 项目类别:
    Collaborative R&D
Manufacturing conductive oxides as catalyst support for energy efficient production of hydrogen and ammonia
制造导电氧化物作为氢和氨节能生产的催化剂载体
  • 批准号:
    2904783
  • 财政年份:
    2024
  • 资助金额:
    $ 40.43万
  • 项目类别:
    Studentship
Development of in situ ammonia capture for enhanced catalytic ammonia synthesis
开发用于增强催化氨合成的原位氨捕获
  • 批准号:
    24K17765
  • 财政年份:
    2024
  • 资助金额:
    $ 40.43万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
EAGER: Enhancement of Ammonia combustion by spatiotemporal control of plasma kinetics
EAGER:通过等离子体动力学的时空控制增强氨燃烧
  • 批准号:
    2337461
  • 财政年份:
    2024
  • 资助金额:
    $ 40.43万
  • 项目类别:
    Standard Grant
Novel High-Efficiency Ammonia engine Technology for Heavy Duty marine applications (HEAT-HD)
适用于重型船舶应用的新型高效氨发动机技术 (HEAT-HD)
  • 批准号:
    10096638
  • 财政年份:
    2024
  • 资助金额:
    $ 40.43万
  • 项目类别:
    Collaborative R&D
Three-dimensional solar-energy-driven hydrogen generation from ammonia
三维太阳能驱动的氨制氢
  • 批准号:
    DP240102787
  • 财政年份:
    2024
  • 资助金额:
    $ 40.43万
  • 项目类别:
    Discovery Projects
Accurate Determination of Branching Fractions in Ammonia Combustion
氨燃烧中支化分数的准确测定
  • 批准号:
    2329341
  • 财政年份:
    2024
  • 资助金额:
    $ 40.43万
  • 项目类别:
    Standard Grant
High-productivity ammonia electrosynthesis
高产氨电合成
  • 批准号:
    LP210301321
  • 财政年份:
    2023
  • 资助金额:
    $ 40.43万
  • 项目类别:
    Linkage Projects
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了